Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 7 (2010), Issue 12 (December)

1. Do ribosomopathies explain some cases of common variable immunodeficiency?
   Clin Exp Immunol, 163(1): 96-103. [Abstract] [Full-text]
2. Do ribosomopathies explain some cases of common variable immunodeficiency?
   Clin Exp Immunol, 163(1): 96-103. [Abstract] [Full-text]
3. Do ribosomopathies explain some cases of common variable immunodeficiency?
   Clin Exp Immunol, 163(1): 96-103. [Abstract] [Full-text]
4. Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.
   Blood, 116(23): 4783-5. [Abstract] [Full-text]
5. Detection, evaluation, and management of iron-restricted erythropoiesis.
   Blood, 116(23): 4754-61. [Abstract] [Full-text]
6. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.
   Blood, 116(23): 5010-20. [Abstract] [Full-text]
7. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance.
   Blood, 116(23): 4771-6. [Abstract] [Full-text]
8. Sickle-cell disease.
   Lancet, 376(9757): 2018-31. [Abstract] [Full-text]
9. Sickle-cell disease.
   Lancet, 376(9757): 2018-31. [Abstract] [Full-text]
10. Adaptation to anemia in hemoglobin E-ß thalassemia.
    Blood, 116(24): 5368-70. [Abstract] [Full-text]
11. Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.
    Blood, 116(24): 5140-8. [Abstract] [Full-text]
12. During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool.
    Blood, 116(24): 5334-46. [Abstract] [Full-text]
13. Twist and shout: one decade of meta-analyses of erythropoiesis-stimulating agents in cancer patients.
    Acta Haematol, 125(1): 55-67. [Abstract] [Full-text]
14. Management of aplastic anemia: the role of systematic reviews and meta-analyses.
    Acta Haematol, 125(1): 47-54. [Abstract] [Full-text]
15. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines.
    Br J Anaesth, 106(1): 13-22. [Abstract] [Full-text]
16. Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome.
    Pediatr Blood Cancer, 56(2): 262-6. [Abstract] [Full-text]
17. Iron in sickle-cell disease: what have we learned over the years?
    Pediatr Blood Cancer, 56(2): 182-90. [Abstract] [Full-text]
18. Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.
    Pediatr Blood Cancer, 56(2): 177-81. [Abstract] [Full-text]
19. Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome.
    Pediatr Blood Cancer, 56(2): 262-6. [Abstract] [Full-text]
20. Iron in sickle-cell disease: what have we learned over the years?
    Pediatr Blood Cancer, 56(2): 182-90. [Abstract] [Full-text]
21. Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.
    Pediatr Blood Cancer, 56(2): 177-81. [Abstract] [Full-text]
22. Protein 4.2 interaction with hereditary spherocytosis mutants of the cytoplasmic domain of human anion exchanger 1.
    Biochem J, 433(2): 313-22. [Abstract] [Full-text]
23. Sickle cell disease and transcranial Doppler imaging: inter-hemispheric differences in blood flow Doppler parameters.
    Stroke, 42(1): 81-6. [Abstract] [Full-text]

© 2004-2012 Anemia Research Today. All Rights Reserved.